Colony-Stimulating Factor-1 Plays a Major Role in the Development of Reproductive Function in Male Mice
Paula E. Cohen,
Matthew P. Hardy and
Jeffrey W. Pollard
Department of Developmental and Molecular Biology (P.E.C.,
J.W.P.), Department of Obstetrics and Gynecology (J.W.P.), Albert
Einstein College of Medicine, Bronx, New York 10461,
Population Council and The Rockefeller University (M.P.H.),
New York, New York 10021
 |
ABSTRACT
|
---|
Colony-stimulating factor-1 (CSF-1) is the
principal regulator of cells of the mononuclear phagocytic lineage that
includes monocytes, tissue macrophages, microglia, and osteoclasts.
Macrophages are found throughout the reproductive tract of both males
and females and have been proposed to act as regulators of fertility at
several levels. Mice homozygous for the osteopetrosis mutation
(csfmop) lack CSF-1 and, consequently,
have depleted macrophage numbers. Further analysis has revealed that
male
csfmop/csfmop
mice have reduced mating ability, low sperm numbers, and 90% lower
serum testosterone levels. The present studies show that this low serum
testosterone is due to reduced testicular Leydig cell steroidogenesis
associated with severe ultrastructural abnormalities characterized by
disrupted intracellular membrane structures. In addition, the
Leydig cells from
csfmop/csfmop
males have diminished amounts of the steroidogenic enzyme proteins P450
side chain cleavage, 3ß-hydroxysteroid dehydrogenase, and P450
17
-hydroxylase-lyase, with associated reductions in the activity of
all these steroidogenic enzymes, as well as in 17ß-hydroxysteroid
dehydrogenase. The CSF-1-deficient males also have reduced serum LH and
disruption of the normal testosterone negative feedback response of the
hypothalamus, as demonstrated by the failure to increase LH secretion
in castrated males and their lack of response to exogenous
testosterone. However, these males are responsive to GnRH and LH
treatment. These studies have identified a novel role for CSF-1 in the
development and/or regulation of the male
hypothalamic-pituitary-gonadal axis.
 |
INTRODUCTION
|
---|
Colony stimulating factor-1 (CSF-1) is a homodimeric growth factor
that regulates the survival, proliferation, motility, and
differentiation of cells of the mononuclear phagocytic lineage (1). The
action of CSF-1 is mediated through a high-affinity cell surface
receptor tyrosine kinase, CSF-1R, which is the product of the
c-fms protooncogene (2) and which is present on all cells
belonging to the mononuclear phagocyte lineage, including terminally
differentiated tissue macrophages, osteoclasts, and microglia of the
brain. The functions for CSF-1 were confirmed in vivo by
observations in mice homozygous for the CSF-1 gene null mutation,
osteopetrotic (csfmop, formerly op)
(3, 4). Phenotypically, these mice lack CSF-1 and have significantly
depleted numbers of macrophages in most tissues and very few
osteoclasts, the latter resulting in the characteristic phenotype,
osteopetrosis (5, 6, 7). Detailed studies on particular macrophage
populations in the nullizygous mice indicated that those macrophages
associated with trophic and/or scavenging functions during development
are the most affected by the absence of CSF-1 whereas those macrophages
associated with immune functions are relatively unaffected (7). In
addition to its expression in mononuclear phagocytes, the CSF-1R is
expressed in oocytes, decidual cells, and trophoblast in females (8, 9), suggesting additional roles for CSF-1 outside the hematopoietic
system. Studies of reproductive function in
csfmop/csfmop mice
revealed female fertility defects characterized by poor ovulatory
rates, small litters, and failure to lactate (10, 11), confirming the
importance of CSF-1 in the female reproductive tract. These studies
also revealed a hitherto unsuspected role for this growth factor in
male fertility regulation.
The absence of CSF-1 in
csfmop/csfmop male mice
results in 90% lower serum testosterone (T) concentrations than wild
type males (10) and is associated with low epididymal sperm numbers and
reduced libido (10). In the testis, CSF-1 regulates the resident
population of testicular macrophages (TMs) (12), which form an intimate
structural relationship with neighboring steroidogenic Leydig cells
(13, 14, 15). In
csfmop/csfmop
males, TM numbers are severely depleted throughout development (12) and
this, together with previous reports of a regulatory role for TMs on
Leydig cell function (for review see 16 , suggests that CSF-1
might act in a paracrine fashion, through TMs, to regulate
steroidogenesis. However, because CSF-1, by acting through microglia,
is involved in the development of functional neuronal processing in the
brain (17), CSF-1 might also act at the level of the hypothalamus and
pituitary to modulate the release of GnRH and/or the gonadotropins, LH
and FSH, such that the LH-mediated regulation of Leydig cell function
is disrupted in
csfmop/csfmop males. The
present studies were aimed at defining the molecular basis of the
fertility defects in
csfmop/csfmop males and
demonstrate that this growth factor plays an essential role in the
development and functioning of the hypothalamic-pituitary-gonadal
axis.
 |
RESULTS
|
---|
Basal Steroidogenesis by Leydig Cells of
csfmop/csfmop
Males
To determine whether the lower serum T levels in
csfmop/csfmop males are
due to decreased testicular steroidogenesis, rather than to increased
metabolic clearance, basal T synthesis by isolated Leydig cells was
assessed and was found to be significantly lower in cells recovered
from csfmop/csfmop than
those from +/csfmop controls (Table 1
). The 86.3% reduction in basal T
synthesis by Leydig cells derived from
csfmop/csfmop males is
similar to the
90% lower serum T observed in these animals (10),
suggesting that the reduction in serum T is due directly to lowered
testicular steroidogenic capacity. Similar T synthesis results were
obtained from incubations of whole testis in vitro (data not
shown).
To examine the cause of the reduced steroidogenesis, the enzymatic
activity of the steroidogenic enzymes in isolated Leydig cells was
examined. Side chain cleavage (P450scc),
3ß-hydroxysteroid dehydrogenase (3ßHSD), P450 17
-hydroxylase
lyase (P45017
), and 17ß-hydroxysteroid dehydrogenase
(17ßHSD) activities are all significantly reduced in isolated Leydig
cells from csfmop/csfmop
males compared with +/csfmop Leydig cells (Table 2
). P450scc catalyzes the
conversion of cholesterol to pregnenolone in the mitochondria. Its
activity in csfmop/csfmop
Leydig cells is reduced to 18.1% of that found in heterozygote Leydig
cells. The activity of 3ßHSD, which is responsible for the conversion
of pregnenolone to progesterone, is reduced to 66.3% of normal.
P45017
is a dual-activity enzyme responsible for the
conversion of progesterone to 17
-hydroxyprogesterone through its
hydroxylase activity and the subsequent formation of androstenedione
through its lyase activity. The hydroxylase activity of
P45017
is reduced to 51.3%, while its lyase activity is
80.5% of normal levels (Table 2
). 17ßHSD, which completes the
pathway by converting androstenedione to T, is also reduced in
csfmop/csfmop Leydig
cells to 40.6% of that seen in +/csfmop Leydig
cells (Table 2
).
To determine the molecular basis for the reduced enzymatic activity in
Leydig cells from
csfmop/csfmop males, the
protein and mRNA concentrations for P450scc, 3ß-HSD, and
P45017
were measured, either in whole testis or in
isolated Leydig cells, or both. Anti-P450scc antibody
detected a single band of 52 kDa in testis, Leydig cells, ovary, and
adrenal extracts but not in spleen (Fig. 1
, A and B). This band corresponds to
that detected in a commercial control sample of purified bovine
mitochondria (see Materials and Methods; Fig. 1A
). The
concentrations of P450scc in whole testicular extracts of
csfmop/csfmop males, when
normalized to glyceraldehyde phosphodehydrogenase (GAPDH) protein
concentration in three separate Western blots, was very significantly
reduced (P < 0.0005, Mann Whitney test, n = 9) to
16.7% of wild type concentrations (Fig. 1A
). These data were confirmed
by examination of an isolated Leydig cell protein extract in which the
level of P450scc enzyme was 14.7% of that found in
heterozygote Leydig cells (Fig. 1B
). Interestingly, however, mRNA
expression of P450scc, as determined by ribonuclease
protection assay (RPA) and normalized to GAPDH mRNA expression, was
similar in the testes of
csfmop/csfmop and
+/csfmop males (Fig. 1C
), indicating a
posttranscriptional effect on the testicular content of this
enzyme.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 1. Analysis of P450scc Expression in the
csfmop/csfmop
Testis
A, Western blot analysis of whole testis protein extracts using a
rabbit antibody raised against the bovine adrenal P450scc.
Lanes 1 to 3, +/csfmop; lanes 4 to 6,
csfmop/csfmop;
lane 7, ovary; lane 8, adrenal; lane 9, spleen; lane 10, control
purified porcine mitochondrial extract. Solid arrowhead
indicates specific band corresponding to P450scc. *,
Significant variation between genotypes (P <
0.0005, Mann Whitney test). B, Western blot analysis of isolated Leydig
cells using the same antibody as in panel A. Lane 1,
+/csfmop; lane 2,
csfmop/csfmop;
lane 3,
C-csfmop/csfmop;
lane 4, ovary; lane 5, spleen. Solid arrowhead indicates
band corresponding to P450scc. C, Autoradiograph of a RPA
to detect mRNA expression of P450scc and GAPDH mRNA in
total RNA isolated from whole testis. Lane 1, P450scc probe
(P1); lane 2, GAPDH probe (P2); lanes 3 to 5,
+/csfmop; lanes 6 to 8,
csfmop/csfmop;
lane 9, ovary; lane 10, adrenal; lane 11, yeast. The protected fragment
for P450scc is 250 bp and for GAPDH is 147 bp. In each
panel (A-C), densitometric analyses (ImageQuant) for means of testes
lanes are presented in the adjoining bar charts. Protein levels were
standardized using GAPDH levels (for whole testis) or cell number (for
isolated Leydig cells). Bars represent arbitrary
units ± SEM].
|
|
The concentration of testicular 3ßHSD in
csfmop/csfmop males was
also found to be significantly reduced compared with that of
+/csfmop males (Fig. 2
, A and B). The specificity of the
anti-3ßHSD antibody was confirmed using protein extracts from COS-1
cells expressing either isoform I or VI, both of which are expressed in
testicular Leydig cells, while only isoform I is found in the adrenal
gland (18). Both isoforms migrate at similar rates on 10%
polyacrylamide gels, having only
2 kDa difference in molecular mass
(18), and both are detected by the antibody. This band migrates at the
same rate as that detected in the steroidogenic tissues, but no
comigratory band was detected in the spleen samples. The 3ßHSD
concentration in whole testis extracts from
csfmop/csfmop males,
determined by densitometric analysis of four separate Western blots, is
43.1% of the +/csfmop level (Fig. 2A
), a figure
that is statistically significant (P < 0.05, Mann
Whitney test, n = 12). In an extract of Leydig cells from
csfmop/csfmop males,
anti-3ßHSD antibody Western blotting detects only 14.8% the amount
of 3ßHSD detected in a Leydig cell extract from
+/csfmop males (Fig. 2B
). Northern blot analysis
of total RNA from +/csfmop and
csfmop/csfmop testes detects a mRNA transcript
of 1.6 kb whose concentration does not differ between genotypes (Fig. 2C
). A similar band is detected in RNA isolated from ovaries and
adrenal glands, but not spleen (Fig. 2C
). These results were confirmed
by a RPA using a probe specific to nucleotides 502839 of the
published mRNA sequence (data not shown).

View larger version (49K):
[in this window]
[in a new window]
|
Figure 2. Analysis of 3ßHSD Expression in the
csfmop/csfmop
Testis
A, Western blot analysis of whole testis protein extracts using a
rabbit anti-human 3ßHSD antibody. Lanes 1 to 3,
+/csfmop; lanes 4 to 6,
csfmop/csfmop;
lane 7, ovary; lane 8, adrenal; lane 9, spleen; lanes 10 and 11, COS-1
cell extracts expressing 3ßHSD isoform I and isoform VI. *,
Significant variation between genotypes (P < 0.05,
Mann Whitney test). B, Western blot analysis of isolated Leydig cells
using the same antibody as in panel A above. Lane 1,
+/csfmop; lane 2,
csfmop/csfmop;
lane 3,
C-csfmop/csfmop;
lane 4, ovary; lane 5, spleen. C, Northern blot analysis of total
testicular RNA (20 µg) probed with a [32P]-labeled cDNA
to 3ßHSD. Lanes 1 to 3, +/csfmop; lanes 4
to 6,
csfmop/csfmop;
lane 7, ovary; lane 8, adrenal; lane 9, spleen. Upper
bands represent unprocessed RNA. In each panel (A-C),
densitometric analyses (ImageQuant) for means of testes lanes are
presented in the adjoining bar charts. Protein levels were standardized
using GAPDH levels (for whole testis) or cell number (for isolated
Leydig cells). Bars represent arbitrary units ±
sem. In all cases, solid arrowheads indicate
specific bands corresponding to 3ßHSD.
|
|
The concentration of P45017
protein is also reduced in
whole testis extracts from
csfmop/csfmop males to
90% of normal (Fig. 3A
) which, although
being only a 10% reduction, is statistically significant
(P < 0.05, Mann Whitney test for the means of two
Western blots, n = 6). The antibody against P45017
detects a band of 52 kDa in protein extracts from testis, Leydig cell,
and ovary, but not in adrenal or splenic samples. In testis and to a
lesser extent in spleen, the antibody also detects a major
cross-reactive band of around 49 kDa. This band is not present in
isolated Leydig cell extracts. The P45017
protein level
in two isolated Leydig cell extracts from
csfmop/csfmop males is
reduced to 44.7% of that seen in heterozygote Leydig cells (Fig. 3B
).
However, P45017
mRNA concentrations are normal in total
RNA extracts from
csfmop/csfmop whole
testis (Fig. 3C
). Expression of the 1.7-kb P45017
message is also detected in ovarian total RNA but not in adrenal and
spleen RNA (Fig. 3C
). The normal expression of P45017
mRNA in csfmop/csfmop
testes was confirmed by RPA (data not shown).

View larger version (54K):
[in this window]
[in a new window]
|
Figure 3. Analysis of P45017 Expression in the
csfmop/csfmop
Testis
A, Western blot analysis of whole testis using a rabbit antibody raised
against porcine testicular P45017 . Lanes 1 to 3,
+/csfmop; lanes 4 to 6,
csfmop/csfmop;
lane 7, ovary; lane 8, adrenal; lane 9, spleen; lane 10, control
purified sheep microsomal extract. B, Representative Western blot
analysis of isolated Leydig cells using the same antibody as in panel A
above. Lanes 1 and 2, +/csfmop; lanes 3 and
4, csfmop/csfmop;
lane 5,
C-csfmop/csfmop;
lane 6, ovary; lane 7, adrenal; lane 8, spleen; lane 9, control
microsomal extract from sheep adrenal gland. C, Northern blot analysis
of total testicular RNA probed with a 32P-labeled cDNA to
P45017 . Lanes 1 to 3,
+/csfmop; lanes 4 to 6,
csfmop/csfmop;
lane 7, ovary; lane 8, adrenal; lane 9, spleen. Upper
bands represent unprocessed RNA. In each panel (A-C),
densitometric analyses (ImageQuant) for means of testes lanes are
presented in the adjoining bar charts. Bars represent
arbitrary units ± SEM and, in the case of the Western
blots, are standardized to GAPDH control levels. In all cases,
solid arrowheads indicate specific bands corresponding
to P45017 . *, Significant variation between genotypes
(P < 0.05, Mann Whitney test).
|
|
Adrenal Steroidogenesis in +/csfmop
and csfmop/csfmop
Males
To test whether adrenal steroidogenesis is also disrupted in
csfmop/csfmop males,
levels of P450scc and 3ßHSD protein in the adrenal gland
were measured by Western blot analysis. Comparison of these enzyme
levels in the adrenal glands of
csfmop/csfmop and
+/csfmop males revealed no differences
between genotypes (Fig. 4
, A and B).
Furthermore, serum corticosterone concentrations in
csfmop/csfmop and
+/csfmop males were also not
significantly different (Fig. 4C).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 4. Adrenal Steroidogenesis in
csfmop/csfmop
Males
A, Western blot analysis of adrenal gland protein extracts using
anti-P450scc antibody. Lanes 1 to 3,
+/csfmop adrenals; lanes 4 to 6,
csfmop/csmop
adrenals; lane 7, +/csfmop ovary; lane 8,
+/csfmop testis; lane 9,
+/csfmop spleen. B, Western blot analysis of
adrenal gland extracts using anti-3ßHSD antibody. Lanes are the same
as those described for panel A. In all cases, solid
arrowheads indicate specific bands corresponding to 3ßHSD. C,
Serum corticosterone concentrations (ng/ml ± SD) in
+/csfmop and
csfmop/csfmop
males (n = 12 for both groups). No statistical difference between
groups.
|
|
Leydig Cell Ultrastructure
To assess the structural consequences of the
csfmop mutation on testicular interstitial
cells, we prepared testes for electron microscopy. The gross morphology
of csfmop/csfmop testes
appears normal (10) (despite the severe depletion of TMs). However,
csfmop/csfmop Leydig
cells had striking ultrastructural irregularities. Tightly coiled
membranous whorls are a normal feature of rodent Leydig cells (19) and
are absent in other testicular cell types. These structures are readily
observed in Leydig cells from +/csfmop males
(Fig. 5A
) and are limited to a small
portion of the cytoplasmic volume. In
csfmop/csfmop males,
however, the membranous whorls occupy the majority of the Leydig cell
cytoplasm, often occluding and displacing the nucleus (Fig. 5B
). The
increased size of the whorls observed in
csfmop/csfmop Leydig
cells appears to result from unravelling of the whorls and/or dilation
of the intermembrane spaces. The membranes of the mitochondria also
appeared to be disrupted, with the occasional loss of cisternal
structures.

View larger version (112K):
[in this window]
[in a new window]
|
Figure 5. Electron Micrographs of Testicular Leydig Cells
Top, +/csfmop; middle,
csfmop/csfmop;
and bottom,
C-csfmop/csfmop
male mice. Bars are 1 µm in length. L, Leydig cell; M,
macrophage.
|
|
Stimulation of Leydig Cell Steroidogenesis Using Gonadotropins and
Intermediate Substrate (22R-Hydroxycholesterol) for Side Chain Cleavage
Enzyme
Since androgen biosynthesis by testicular Leydig cells is
regulated by pituitary LH, the low T output in
csfmop/csfmop males might
result from reduced Leydig cell sensitivity to LH. Therefore,
LH-stimulated T synthesis by isolated Leydig cells derived from
+/csfmop and
csfmop/csfmop males was
measured (Table 1
). As expected, LH stimulated T synthesis by Leydig
cells taken from heterozygote males by 13-fold. Similarly, LH
stimulated basal T synthesis in
csfmop/csfmop Leydig
cells to a level that, although still significantly lower than control
values, was factorially greater (65-fold) as a result of the lower
basal T concentration. Similar responses were obtained in
vivo by treating mice with a single dose of the LH analog, human
chorionic gonadotropin (hCG), and measuring serum T concentrations
1 h later. In confirmation of previous data (10), basal serum T
concentrations were reduced by
90% in
csfmop/csfmop males.
Heterozygous males responded to hCG injection with an 11-fold increase
in circulating concentrations of T (Table 3
). Circulating T levels rose even
more dramatically (147-fold) in
csfmop/csfmop
males to a concentration equivalent to that of hCG-stimulated control
males (Table 3
). Together, these results, confirmed by analysis of
LH-stimulated T synthesis by whole testes in vitro (data not
shown), demonstrate that the steroidogenic ability of
csfmop/csfmop males can
be enhanced greatly by gonadotropin treatment both in vitro
and in vivo, indicating that a sufficient number of LH
receptors are present to elicit steroidogenic responses comparable to
that of wild type males.
To distinguish between LH-stimulated and LH-independent events during
the early stages of steroidogenesis, T synthesis by isolated Leydig
cells was assessed in the presence of 22R-hydroxycholesterol
(22R-CHOL), a steroid intermediate substrate for the enzyme
P450scc. Addition of 22R-CHOL to Leydig cell cultures
bypasses the early LH-regulated events involving P450scc,
as well as cholesterol mobilization from the intracellular lipid stores
(20), but does not bypass the requirement for P450scc
activity. 22R-CHOL stimulation results in similar T output in control
and csfmop/csfmop Leydig
cell groups and is comparable to the LH response (Table 1
). However,
the level of stimulation in
csfmop/csfmop Leydig
cells is far greater than that of +/csfmop
Leydig cells due to the differences in basal T synthesis between
genotypes.
Hypothalamic-Pituitary Function in
csfmop/csfmop
Males
The steroidogenic failure in
csfmop/csfmop males might
be due to low circulating LH concentrations. For this reason, serum LH
concentrations were measured by RIA. Basal serum LH in
csfmop/csfmop males is
90% lower than that of heterozygote males (Table 4
). Treatment with the potent GnRH
agonist, histerilin, at a dose shown to cause maximal stimulation (data
not shown), increases serum LH by 35-fold in
csfmop/csfmop males,
compared with a 5-fold increase in +/csfmop
males (Table 4
). Despite this large stimulation, however,
histerilin-treated LH levels remain significantly lower in
csfmop/csfmop males than
in heterozygote controls. Interestingly, at a dose of 1 ng histerilin
per g body weight,
csfmop/csfmop males
displayed a 10-fold increase in serum LH. However, this dose was not
sufficient to stimulate LH secretion in +/csfmop
males, whose serum LH concentrations remained at basal levels. Thus at
this dose, the serum LH concentrations were comparable between
genotypes.
View this table:
[in this window]
[in a new window]
|
Table 4. Serum LH Concentrations in
csfmop/csfmop Male Mice
before and after Treatment with the GnRH Agonist, Histerilin, or 5 Days
after Bilateral Orchidectomy
|
|
Serum FSH concentrations were also significantly reduced in
csfmop/csfmop males
(P < 0.001, Mann-Whitney test). However, this
reduction was not as great as that for serum LH; serum FSH in
+/csfmop males was 6.87 ± 1.07 ng/ml (mean
of 30 samples ± SEM) compared with 2.19 ± 0.34
ng/ml for csfmop/csfmop
males (10 samples), representing a 70% reduction in circulating FSH.
Histerilin treatment, at a dose of 100 ng/g body weight, increased
serum FSH concentrations by 4-fold in both
+/csfmop and
csfmop/csfmop males, to
24.19 ± 2.80 ng/ml (13 mice) and 7.84 ± 2.93 ng/ml (11
mice), respectively.
To investigate the negative feedback sensitivity of
csfmop/csfmop males,
heterozygote and homozygote mutant mice were subjected to either
bilateral orchidectomy or sham surgery, and serum samples were obtained
5 days later. Serum LH concentrations in bilaterally orchidectomized
+/csfmop males was 1.8-fold higher than in
control males, as would be expected by release of negative feedback
(Table 4
), while sham-operated males showed no such stimulation (not
shown). In contrast, bilateral orchidectomy had no effect on the serum
LH concentrations in
csfmop/csfmop males,
indicating a loss of feedback sensitivity in these males. Furthermore,
treatment with physiological concentrations of T postpubertally results
in elevated, although not significant (P < 0.06),
basal LH concentrations as compared with that of untreated
csfmop/csfmop males.
These effects of both castration and T treatment contradict the
expectation that low serum T would increase, while high serum T would
decrease, circulating LH concentrations via the classic negative
feedback regulatory system. Taken together, these studies suggest that
the pituitaries of
csfmop/csfmop males are
able to respond to GnRH by increasing gonadotropin output to a higher
level, but that the hypothalamic-pituitary response to circulating
androgen is disrupted in these mice.
Effect of CSF-1 on Reproductive Function in
csfmop/csfmop
Males
To investigate the effect of postnatal restoration of serum CSF-1
concentrations on male reproductive function,
csfmop/csfmop males were
treated with human recombinant CSF-1 (hrCSF-1) from day 2 of life
(C-csfmop/csfmop). This
regimen has been shown in previous studies to restore circulating
concentrations of CSF-1 (7). Leydig cells obtained from CSF-1-treated
csfmop/csfmop males
produce significantly more T (
2.3-fold) than those from
untreated csfmop/csfmop
Leydig cells (Table 1
), but their T synthesis is not restored to wild
type levels, in line with the failure of hrCSF-1 treatment to restore
circulating T concentrations in these mice (10). LH treatment of
C-csfmop/csfmop Leydig
cells results in stimulation of T synthesis to the same level of
LH-stimulated heterozygote Leydig cells (Table 1
), while 22R-CHOL
treatment produces a level of T synthesis that is only 62.7% of the
level of 22R-CHOL-stimulated +/csfmop Leydig
cells, despite being 27-fold stimulated from basal levels (Table 1
).
Interestingly, however, Leydig cells isolated from CSF-1-treated
C-csfmop/csfmop males
contain increased, and often almost normal, protein levels for
P450scc (74.2% of wild type level; Fig. 1B
), 3ßHSD
(93.9% of the +/csfmop level; Fig. 2B
) and
P45017
(68.5% of wild type levels; Fig. 3B
). The
recovery of steroidogenic enzyme proteins in
C-csfmop/csfmop Leydig
cells and testis is associated with the restoration of apparently
normal Leydig cell ultrastructure in these mice (Fig. 5C
).
To investigate the effect of CSF-1 treatment on hypothalamic-pituitary
function in csfmop/csfmop
males, serum LH concentrations were measured as described in
Materials and Methods. While basal LH concentrations in
untreated csfmop/csfmop
males is 7.4% of the normal circulating concentration, CSF-1 treatment
results in a significant increase (2.5-fold) in LH concentrations to
18.2% of normal, consistent with the increased basal synthesis of T by
Leydig cells.
 |
DISCUSSION
|
---|
The osteopetrotic mouse mutation, a null mutation in the CSF-1
gene located on chromosome 3, results in a complete absence of systemic
CSF-1 (3, 4). Cells of the mononuclear phagocytic lineage, including
microglia, tissue macrophages, and osteoclasts, express the
transmembrane tyrosine kinase CSF-1 receptor (the c-fms
protooncogene product). Many populations of these cells are depleted in
the nullizygous animals, including osteoclasts, the latter resulting in
the characteristic osteopetrosis (5, 7, 21, 22). In addition, in the
female reproductive tract the CSF-1 receptor is also expressed in
oocytes, decidual cells, and trophoblast, and several studies have
confirmed roles for CSF-1 in ovulation and during pregnancy (8, 11, 23, 24, 25). It was also observed that male
csfmop/csfmop mice display fertility
defects characterized by a reduction in libido and reduced sperm number
(10). Such defects could be ascribed to the reduced circulating and
intratesticular T concentrations in the mutant mice. The present
studies have shown conclusively that this reduction in T concentration
is due to reduced Leydig cell steroidogenic enzymic activity, with
the most affected step being the conversion of cholesterol to
pregnenolone catalyzed by P450scc. The reduced
steroidogenesis was also associated with a reduction of greater than
90% in circulating LH concentration, while treatment of Leydig cells,
testicular cultures, or intact mice with pharmacological doses of LH
elevated T concentration and T synthesis to levels similar to those of
wild type mice. Furthermore, serum LH concentrations themselves can be
restored by treatment of
csfmop/csfmop mice with a
GnRH agonist. These data strongly suggest a defect in the
hypothalamic-pituitary axis of
csfmop/csfmop mice, a
defect that was confirmed by our studies showing a loss of T-feedback
sensitivity in these mice. Since cells of the mononuclear phagocytic
lineage are the only cells in males that have been shown to express the
CSF-1R, these profound defects in the hypothalamic-pituitary-gonadal
axis show that mononuclear phagocytes play an important role in the
establishment and functioning of this neuroendocrine axis.
The hypothalamus is the primary regulator of sexual function,
liberating GnRH in a pulsatile fashion which, in turn, stimulates
release of LH from the pituitary (26). The hypothalamus is rich in
mononuclear phagocytic-lineage microglial cells (27) that express the
CSF-1R and respond in culture to CSF-1 (17). Although hypothalamic
populations of microglia have not been studied in
csfmop/csfmop mice, in
the retina the acquisition of these cells is delayed during development
(7). Furthermore, adult
csfmop/csfmop mice have
intracortical processing problems associated with deficits in both
excitatory and inhibitory neuronal firing, even though at a gross
morphological level, anatomical abnormalities could not be detected in
the cortical regions of the brain (17). In culture, CSF-1 is a trophic
factor for embryonic neurons derived from many areas of the brain
including the hypothalamus, provided that microglia are present in the
cultures (17). Together, these data suggest that CSF-1 acting through
the microglia plays an important developmental role in the
establishment of brain function including hypothalamic function.
However, these actions in the hypothalamus and pituitary must be fairly
specific since adrenal steroidogenesis is unaffected, suggesting normal
secretion of CRF by the parvocellular neurons and the subsequently
normal release of ACTH from anterior pituitary corticotrophs.
While it is reasonable to conclude that the reduced steroidogenic
capacity of csfmop/csfmop
Leydig cells is due to the low circulating LH in adult mice, there are
a number of paradoxical observations that suggest there might also be a
local requirement for CSF-1 in the testis. Our data show that all the
steroidogenic enzyme activities are reduced, with P450scc
being the most depressed, consistent with the reduction in protein
concentration observed. However, the mRNA concentrations for these
enzymes are unaffected, suggesting that the deficit is
posttranscriptional. This is contrary to expectation for a deficiency
of LH, since this gonadotropin has been shown to regulate
steroidogenic enzyme mRNA expression (28, 29). Furthermore, while
the activity of P45017
is most affected by LH (30, 31),
in the csfmop/csfmop
mouse this enzyme is the least affected, whereas P450scc
whose activity is relatively less modulated by LH (31), is the most
affected by the csfmop mutation. Although,
experimentally, the consequence of maintaining LH concentrations at
10% in a pulsatile manner in wild type mice throughout life is
unknown, the data suggest that there may also be local influences of
CSF-1 in the testis interacting with the systemic regulation by LH.
Interestingly, despite its statistical significance, the reduction in
serum FSH in
csfmop/csfmop males is
not sufficient to cause any severe effects on the gross testicular
morphology and seminiferous tubule cytology.
There is a large body of literature reporting both anatomical and
physiological interactions between Leydig cells and TMs. The idea that
TMs and Leydig cells are functionally coupled arose from the
characterization of their unique structural relationship, together with
the observations that vasectomy causes simultaneous destruction of both
cell types (32), while pharmacological depletion of either cell type
has severe consequences on the performance of the other cell type
(33, 34, 35, 36). The appearance of adult Leydig cells during puberty occurs in
an environment in which the TM population is already established (12, 15, 16, 37, 38) and is prevented when TMs are pharmacologically ablated
before puberty (36). In adult males, the removal of TMs results in
disruption of Leydig cell steroidogenesis (for review see 16 . In
addition, TM-conditioned media, as well as cytokines that can be
macrophage-derived (including tumor necrosis factor-
and
interleukin-1), alter the steroidogenic function of Leydig cells
in vitro (39, 40, 41, 42, 43). We have shown that CSF-1 is the major
regulator of TMs, the only testicular cell type that expresses CSF-1R
(10), and that this macrophage population is severely depleted in
csfmop/csfmop mice
throughout development. This depletion of macrophages in the CSF-1
nullizygous testis, therefore, is likely to have significant
consequences for the functioning of Leydig cells. Consistent with this
is the disruption of Leydig cell morphology in the mutant.
Interestingly, an increase in abundance and/or disruption of the Leydig
cell membranous whorls has also been described in other testicular
perturbation models, such as in experimentally cryptorchid rats (44)
and rats with experimentally induced damage to the seminiferous tubules
(45), which are also deficient in steroidogenesis (46, 47). The
functional significance of these whorls remains unknown, but previous
studies in wild type mice have demonstrated that the whorls are
contiguous with the smooth endoplasmic reticulum (SER), suggesting they
are regional modifications of their system (48). Since three of the
testosterone-biosynthetic enzymes are intimately associated with the
SER, the membrane disruptions seen in the
csfmop/csfmop
males might result in destabilization of these enzymes with the
consequent reduction in protein content without significant effects on
mRNA concentration. Interestingly, P450scc, the enzyme that
is the most affected by the csfmop mutation,
resides in the mitochondria and is therefore unaffected by the
disruption of the endoplasmic reticular system. However, our
preliminary ultrastructural analysis indicates that there might be
similar, albeit more subtle, disruptions of the mitochondria in
csfmop/csfmop Leydig
cells. This idea that enzyme activities are perturbed as a result of
physical disruption of Leydig cell architecture is supported by the
observation that treatment of the nullizygous mice from birth with
CSF-1 corrects both the TM population and Leydig cell morphology and
restores steroidogenic enzyme protein levels to near wild type
concentrations without completely correcting the steroidogenic
deficiencies. It is interesting to note that, despite the remarkable
ultrastructural defects in the Leydig cells of
csfmop/csfmop males, they
are still capable of responding acutely to hCG/LH treatment both
in vitro and in vivo, suggesting, perhaps, that
the total surface area of SER is not reduced in these cells, despite
the obvious membrane disruption.
Androgen biosynthesis by testicular Leydig cells is required for normal
reproductive function in adult males, as well as for the processes of
sexual differentiation and puberty. During sexual differentiation, a
surge of T secretion by Leydig cells of the fetal testis masculinizes
the hypothalamic-pituitary axis (49). However, disrupting pituitary
secretion of LH and FSH by a targeted mutation of their common
-chain does not affect gonadal development until after birth (50)
despite the requirement for T during pituitary development, suggesting
that neonatal and, perhaps early postnatal, Leydig cell T synthesis
occurs independently of gonadotropins. During puberty, another surge of
T secretion is required to initiate changes in the hypothalamus and
pituitary, resulting in an alteration in the pattern of GnRH release
from the hypothalamus (49). This resetting of the GnRH system at
puberty results in maturation of the classic T-mediated negative
feedback loop from the testis to the hypothalamic-pituitary axis and
the subsequent onset of fecundity (49, 51, 52). Disruptions in T
biosynthesis by Leydig cells as a consequence of the absence of TMs in
csfmop/csfmop males
during development might have a significant impact on the establishment
of this feedback loop, in a manner observed in the nullizygous mice.
Furthermore, Gaytan et al. (35) suggested that TMs produce a
factor that directly affects hypothalamic-pituitary development. These
observations, together with the physiological interactions between
Leydig cells and TMs, suggest that the phenotype of
csfmop/csfmop males might
result from a complex mix of the actions of CSF-1 in the hypothalamus,
pituitary, and testis during development.
All the reproductive defects described in this paper can be ascribed to
the lack of CSF-1. However, restoration of circulating CSF-1 during the
postnatal period only partially restores many of these deficits. This
may be due to a requirement for embryonic or local synthesis of CSF-1
or, because CSF-1 is synthesized in a variety of forms (including cell
surface, secreted, and secreted proteoglycanated forms), there may be a
requirement for a form other than the soluble human recombinant form
administered. Indeed, evidence has been obtained for both local and
humoral actions of CSF-1 in regulating other mononuclear phagocytic
populations (7).
These studies in the
csfmop/csfmop mouse model
provide compelling evidence that CSF-1 plays a fundamental role in the
establishment and functioning of the hypothalamic-pituitary-gonadal
axis, through its action on macrophages or microglia. This unique role
for CSF-1/macrophage interactions in male reproductive function will
have a significant impact on the understanding of the development of
classic endocrine feedback systems and the involvement of immune cells
in these processes.
 |
MATERIALS AND METHODS
|
---|
Animals
Homozygous mutant
(csfmop/csfmop) and
heterozygous (+/csfmop) male mice were used
at 12 weeks of age, and all studies were performed under the NIH
guidelines for the care and treatment of experimental laboratory
rodents. Animals undergoing CSF-1 treatment
(C-csfmop/csfmop) were
injected subcutaneously daily from day 2 of life with 12 µg of human
recombinant CSF-1 (hrCSF-1; a generous gift of Chiron Corp.,
Emeryville, CA) in 0.05 ml 0.9% saline.
Bilateral orchidectomies were performed under methoxyflurane
anesthesia (Metofane, Pittman-Moore Inc., Mundelein, IL).
Sham-operated animals received similar surgical treatment without
testicular excision. The mice were allowed to recover for 5 days before
blood sampling.
Hormone Treatments and RIAs
To assess the effects of hCG treatment in vivo,
heterozygote and homozygote mutant males were injected with 5 IU hCG
per 10 g body weight (ip), and blood samples were obtained 1
h later for serum T measurement. For GnRH agonist experiments,
histerilin was administered subcutaneously (at doses of 1, 50, or 100
ng per gram body weight in 0.9% saline solution containing 5%
mannitol), 3 h prior to blood sampling. Sera from mice injected
with histerilin or vehicle alone were analyzed by RIA for LH. Animals
undergoing T treatment were given an subcutaneous Silastic implant
containing T in arachis oil (0.6 mg/ml) from 10 weeks of age
(T-csfmop/csfmop).
Implants were constructed as previously described (53).
T concentrations were assessed by RIA using a commercially available
kit (DSL Inc., Webster, TX). Inter- and intraassay coefficients of
variance were 38.8% and 3.0%, respectively. LH RIAs were performed as
previously described (54). Inter- and intraassay coefficients of
variance were 26.9% and 6.7%, respectively.
Serum corticosterone concentrations were measured using a commercially
available kit (Diagnostic Products Corp., Los Angeles, CA).
Leydig Cell Isolation and Treatment
Leydig cells were isolated as previously described (55) and
subjected to 3 h of incubation at 34 C in the presence or absence
of either LH (100 ng/ml) or 22R-hydroxycholesterol (22R-CHOL: 5
µM). For each isolation procedure, eight to ten
age-matched males were used. For each tube, 100,000 cells were
incubated in a total volume of 0.5 ml, and incubations were performed
in quadruplet. Media T content was assessed by RIA.
Western Blotting
Soluble protein extracts from 50,000 Leydig cells or transfected
COS-1 cells or from testis, adrenals, ovaries, and spleen samples were
used for Western blotting as previously described (56). Steroidogenic
enzyme proteins were detected using the Boehringer Mannheim
chemiluminescence Western blotting kit (Indianapolis, IN) and
antibodies raised in rabbits against bovine adrenal
P450scc, human placental 3ß-HSD, and porcine testicular
P45017
. Densitometric analyses were performed using
ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Whole testis
Western blot densitometry represents the means (± SD) of
at least three separate Western blots (and, therefore, at least nine
different testis samples for each genotype). The quantification was
shown to be linear within the range of protein concentrations used
(data not shown), and all protein concentrations were normalized to
GAPDH protein levels on the same blots. Additional controls were used
for each specific antibody; for P450scc and
P45017
, samples of purified bovine mitochondria or
purified sheep microsomes (Oxygene Dallas Corp., Dallas, TX) were run
at the same time as the testis samples, while for 3ß-HSD, cell
extracts were prepared from COS-1 cells transfected with
cytomegalovirus-driven expression vectors containing the entire cDNA
for 3ß-HSD isoforms I or VI (see below). Each antibody showed
specificity for its respective enzyme, as determined by antigen
localization in other steroidogenic tissues (adrenal and ovary) and the
absence of antigen in nonsteroidogenic tissue (spleen). The antibodies
detected proteins of 52 kDa for P450scc, 46 kDa for
3ß-HSD, 52 kDa for P45017
, and 36 kDa for GAPDH.
All of the primary antibodies used were generous gifts from various
sources: anti-P450scc and anti-P45017
(both
from Dr. Dale Buchanan Hales, Department of Physiology and Biophysics,
University of Illinois, Chicago, IL), anti-3ßHSD (Dr. Ian Mason,
Department of Biochemistry and Obstetrics and Gynecology, Southwestern
Medical School, Dallas, TX), and anti-GAPDH (Dr. Y. G. Yeung,
Department of Developmental and Molecular Biology, Albert Einstein
College of Medicine, Bronx, NY).
Transient Expression of 3ßHSD Isoforms
Expression vectors containing the cytomegalovirus-driven
full-length cDNA for 3ßHSD isoform I and 3ßHSD isoform VI
were generously provided by Dr Anita Payne (Department of Obstetrics
and Gynecology, Stanford University, Stanford, CA). Transient
expression in COS-1 cells was obtained using the
diethylaminoethyl-dextran method as described (57). Seventy-two hours
after transfection, the cells were harvested, and soluble protein
extracts were prepared as described above.
Measurement of Steroidogenic Enzyme Activity in Freshly Isolated
Leydig Cells
With the exception of P450scc, steroidogenic enzyme
activities were measured by incubation of purified Leydig cells with
radiolabeled substrates and separation of products by TLC as described
by OShaughnessy and Payne (58). Reaction mixture (0.5 ml) was
prepared in Leydig cell medium that contained 1 µM
substrate (1 µCi, 1 µM) in Leydig cell culture medium.
The reaction mixture was maintained at pH 7.2. Reactions were initiated
by adding to the reaction mixture an aliquot of 0.1 x
106 preincubated intact Leydig cell suspension, using
endogenous cofactors. The reaction mixtures, conducted in triplicate,
were maintained at 34°C in a shaking water bath for 30 min. With this
incubation time, the conversion of substrates to products was linear
with respect to cell number and time of incubation. Reactions were
terminated by adding ice-cold ethyl acetate, and steroids were rapidly
extracted. The organic layer was dried under nitrogen. The steroid
residues were chromatographed on TLC plates, and radioactivity was
measured with a scanning radiometer (System 200/AC3000, Bioscan, Inc.,
Washington, DC).
Activity of P450scc was determined by measuring the
conversion of side-chain-labeled
[26,27-3H]25-hydroxycholesterol to
[3H]4-hydroxyl-4-methyl-pentanoic acid as previously
described (59). 25-Hydroxycholesterol, rather than cholesterol, was
used as substrate to measure the P450scc reaction, since it
does not depend on active transfer to the inner mitochondrial membrane
and has a high aqueous solubility. The reaction was performed in 0.5 ml
of medium containing 0.1 x 106 cells and 1
µM substrate for 30 min. Blank incubations were performed
with medium containing BSA (1.5 mg/ml) in place of cell suspension. At
the end of the incubation, 0.1 ml 1 M NaOH was added
followed by 0.5 ml phosphate buffer adjusted to pH 13. Nonmetabolized
substrate was removed by extracting twice with chloroform. An aliquot
was counted in a liquid scintillation counter. Counts from the blank
incubation were subtracted from the counts in the test system.
[26,27-3H]25-hydroxycholesterol (specific activity, 81.9
Ci/mmol), [7-3H(N)]-pregnenolone (specific activity, 25
Ci/mmol), [1,2-3H(N)]-17
-hydroxyprogesterone (specific
activity, 48.7 Ci/mmol),
[1ß,2ß-3H(N)]-androstenedione (specific activity,
45.3 Ci/mmol), and [1,2,6,7-3H(N)]-testosterone (specific
activity, 101 Ci/mmol) were purchased from Dupont-New England Nuclear
(Boston, MA). [1,2,6,7-3H(N)]-Progesterone (specific
activity, 92 Ci/mmol) was purchased from Amersham International PLC
(Amersham, England). 25-Hydroxycholesterol, pregnenolone, progesterone,
17
-hydroxyprogesterone, androstenedione, and T were purchased from
Sigma Chemical Co. (St. Louis, MO). TLC plates (Baker-flex/UV254) were
obtained from J.T. Baker, Inc. (Phillipsburg, NJ).
Northern Blot Analysis
Probes for Northern blots were obtained by RT-PCR using pairs of
oligonucleotide primers designed from the published sequences of genes
encoding the following steroidogenic enzymes: mouse
P45017
, 5'-CCA GAC GTG GTC ATA TGC ATG CCA-3' and 5'-GAT
GAG CGT AGA CAG ATC TCG GGA-3' (60); and mouse 3ß-HSD, 5'-TGG TCT GAT
CCA TAC CCA TAC AGC-3' and 5'-TGG TGC GGG GTG TCA TCT GAG ATG-3' (61).
Aliquots of 20 µg total mRNA, isolated as previously described (62, 63), were separated by agarose gel electrophoresis and transferred to
nitrocellulose membrane using routine methods. After a 3-h incubation
in prehybridization buffer at 45 C, [32P]-labeled probes
were allowed to hybridize to the blots overnight at 42 C, before high
stringency washing at 55 C and exposure to autoradiographic film for
appropriate lengths of time.
RPAs
For RPA, [32P]-labeled antisense riboprobes were
prepared from cDNA templates cloned into the pCRII vector (InVitrogen
Corp., San Diego, CA). The templates were prepared by RT-PCR using
pairs of oligonucleotide primers designed from the published sequences
of genes encoding the following steroidogenic enzymes: rat
P450scc, 5'-CCG CTT TGC CTT TGA GTC CAT-3' and 5'-ACA CCC
AGA ACT TCT ACT GGG-3' (64); mouse P45017
(see above);
and mouse 3ß-HSD (see above). Aliquots of 20 µg total RNA were
combined with approximately 105 cpm labeled riboprobe and
analyzed by RPA using standard techniques. Consistent mRNA loading was
ensured by the simultaneous hybridization to
[32P]-labeled antisense probe transcribed from the
pTRI-GAPDH-mouse antisense control template (Ambion, Austin, TX), which
contains a fragment of the mouse glyceraldehyde 3-phosphate
dehydrogenase housekeeping gene. Protected RNA fragments were separated
on a denaturing 6% PAGE/8 M urea gel and visualized by
exposing the dehydrated gel to Hyperfilm (Amersham Life Sciences Inc.,
Arlington Heights, IL) for appropriate periods of time.
Electron Microscopy
Male +/csfmop,
csfmop/csfmop,
C-csfmop/csfmop mice were
given a single dose of heparin (130 mU per g body weight ip) and
anesthetized 15 min later. Mice were perfused transcardially for 30 min
with fixative (1.3% sym-collidine, 1.2% acrolein, 25% glutaraldehyde
in 45 µM HCl) before removal of both testes. The testes
were stored in fresh fixative at 4 C until processing by conventional
methods.
 |
ACKNOWLEDGMENTS
|
---|
The authors wish to acknowledge, with gratitude, the help of Dr.
Ren-Shan Ge for performing the enzyme activity assays and Ms. Chantal
Sottas for her excellent technical assistance. In addition, our thanks
go to Drs. A. H. Payne, D. B. Hales, I. Mason, and Y. G.
Yeung for providing reagents and antibodies for the current studies. LH
reference preparation (AFP-7187B) and anti-rat LH antibody
(NIDDK-rLH-s-11) were generously provided by the National Hormone and
Pituitary Program. We also thank Drs. W. Bardin, F. Pixley, and A.
Hapel for critical comments on this manuscript.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Jeffrey W. Pollard, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10451.
This work was funded by the Population Council (M.P.H.) and by grants
from the NIH: R29-HD32588 (to M.P.H.) and HD/AI 30280 (to J.W.P.), The
Albert Einstein Core Cancer Grant P30-CA13330 (to J.W.P.), and Chiron
Corporation (to J.W.P.). J.W.P. is a Monique Weill-Caulier Scholar.
Received for publication November 19, 1996.
Revision received June 9, 1997.
Accepted for publication July 24, 1997.
 |
REFERENCES
|
---|
-
Stanley ER, Guilbert LT, Tushinski RJ, Bartelmez SH 1983 CSF-1 A mononuclear phagocyte lineage-specific hemopoietic growth
factor. J Cell Biochem 21:151159[Medline]
-
Sherr CJ, Rettenmier CW, Sacca R, Roussel MS, Look AT,
Stanley ER 1985 The c-fms proto-oncogene product is related
to the receptor for the mononuclear phagocyte growth factor, CSF-1.
Cell 41:665676[Medline]
-
Wiktor-Jedrzejczak W, Bartocci A, Ferrante Jr AW,
Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER 1990 Total absence of
colony-stimulating factor 1 in the macrophage-deficient osteopetrotic
(op/op) mouse. Proc Natl Acad Sci USA 87:48284832[Abstract]
-
Yoshida H, Hayashi SI, Kunisada T, Ogawa M, Nishikawa S,
Okamura H, Sudo T, Shultz LD, Nishikawa S-I 1990 The murine mutation
osteopetrosis in the coding region of the macrophage colony stimulating
factor gene. Nature 345:442444[CrossRef][Medline]
-
Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, Skelly RR 1982 Hematological characterization of congenital osteopetrosis in
op/op mouse. J Exp Med 156:15161527[Abstract]
-
Marks Jr SC, Lane PW 1976 Osteopetrosis, a new recessive
skeletal mutation on chromosome 12 of the mouse. J Hered 67:1118[Medline]
-
Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R,
Fleisch H, Chisholm O, Hofstetter W, Pollard JW, Stanley ER 1994 Role
of colony stimulating factor-1 in the establishment and regulation of
tissue macrophages during postnatal development of the mouse.
Development 120:13571372[Abstract/Free Full Text]
-
Arceci RJ, Pampfer S, Pollard JW 1992 Expression of
CSF-1/c-fms and SF/c-kit mRNA during
preimplantation mouse development. Dev Biol 151:18[Medline]
-
Arceci RJ, Shanahan F, Stanley ER, Pollard JW 1989 Temporal
expression and location of colony-stimulating factor 1 (CSF-1) and its
receptor in the female reproductive tract are consistent with
CSF-1-regulated placental development. Proc Natl Acad Sci USA 86:88188822[Abstract]
-
Cohen PE, Chisholm O, Arceci RJ, Stanley ER, Pollard JW 1996 Absence of colony stimulating factor-1 in osteopetrotic
(csfmop/csfmop) mice
results in male fertility defects. Biol Reprod 55:310317[Abstract]
-
Cohen PE, Zhu L, Pollard JW 1997 The absence of CSF-1 in
osteopetrotic
(csfmop/csfmop) mice
disrupts estrous cycles and ovulation. Biol Reprod 56:110118[Abstract]
-
Pollard JW, Dominguez MG, Mocci S, Cohen PE, Stanley ER 1997 Effect of colony stimulating factor-1 (CSF-1) null mutation,
osteopetrotic (csfmop), on the distribution of
macrophages in the male reproductive tract. Biol Reprod 56:12901300[Abstract]
-
Miller SC, Bowman BM, Rowland HG 1983 Structure,
cytochemistry, endocytotic activity and immunoglobulin (Fc) receptors
of rat testicular interstitial-tissue macrophages. Am J Anat 168:113[Medline]
-
Niemi M, Sharpe RM, Brown RA 1986 Macrophages in the
interstitial tissue of the rat testis. Cell Tissue Res 243:337344[Medline]
-
Hutson JC 1992 Development of cytoplasmic digitations between
Leydig cells and testicular macrophages of the rat. Cell Tissue Res 267:385389[Medline]
-
Hutson JC 1994 Testicular macrophages. Int Rev Cytol 149:99143[Medline]
-
Michaelson MD, Bieri PL, Mehler MF, Xu H, Arezzo JC, Pollard
JW, Kessler JA 1996 CSF-1 deficiency in mice results in abnormal brain
development. Development 122:112[Abstract/Free Full Text]
-
Abbaszade IG, Arensburg J, Park C-H, J, Kasa-Vubu JZ,
Orly J, Payne AH 1997 Isolation of a new mouse
3ß-hydroxysteroid dehydrogenase isoform, 3ß-HSD VI, expressed
during early pregnancy. Endocrinology 138:13921399[Abstract/Free Full Text]
-
Christensen AK, Fawcett DW 1995 The fine structure of
testicular interstitial cells in mice. Am J Anat 118:551572
-
De Kretser DM, Kerr JB 1994 The cytology of the testis. In:
Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press
Ltd., New York, pp 11771290
-
Wiktor-Jedrzejczak W, Gordon S 1996 Cytokine regulation of the
macrophage (M
) system studied using the colony stimulating
factor-1-deficient op/op mouse. Physiol Rev 76:927947[Abstract/Free Full Text]
-
Wiktor-Jedrzejczak W, Urbanowska E, Aukerman SL, Pollard JW,
Stanley ER, Ralph P, Ansari AA, Sell KW, Szperl M 1991 Correction by
CSF-1 of defects in the osteopetrotic op/op mouse suggests
local, developmental, and humoral requirements for this growth factor.
Exp Hematol 19:10491054[Medline]
-
Pollard JW, Stanley ER 1996 Pleiotropic roles for CSF-1 in
development defined by the mouse mutation osteopetrotic
(op). Adv Dev Biochem 4:153193
-
Pollard JW, Hunt JW, Wiktor-Jedrzejczak W, Stanley ER 1991 A
pregnancy defect in the osteopetrotic (op/op)
mouse demonstrates the requirement for CSF-1 in female fertility. Dev
Biol 148:273283[Medline]
-
Arceci RJ, Pampfer S, Pollard JW 1992 Role and expression of
colony-stimulating factor-1 and steel factor receptors and their
ligands during pregnancy in the mouse. Reprod Fertil Dev 4:619632
-
Haisenleder DJ, Dalkin AC, Marshall JC 1994 Regulation of
gonadotropin gene expression. In: Knobil E, Neill JD (eds) The
Physiology of Reproduction. Raven Press Ltd., New York, pp
17931813
-
Barron KD 1995 The microglial cell. A historical review.
J Neurol Sci 134 [Suppl 1]:5768
-
Payne AH, Youngblood GL 1995 Regulation of expression of
steroidogenic enzymes in leydig cells. Biol Reprod 52:217225[Abstract]
-
Scott IS, Charlton HM, Cox BS, Grocock CA, Sheffield JW,
OShaughnessy PJ 1990 Effect of LH injections on testicular
steroidogenesis, cholesterol side-chain cleavage P450 mRNA content and
leydig cell morphology in hypogonadal mice. J Endocrinol 125:131138[Abstract]
-
Payne AH, Sha L 1991 Multiple mechanisms for regulation of
3ß-hydroxysteroid
dehydrogenase/
5-
4-isomerase,
17
-hydroxylase/C17-20 lyase cytochrome P450, and
cholesterol side-chain cleavage cytochrome P450 messenger
ribonucleic acid levels in primary cultures of mouse Leydig
cells. Endocrinology 129:14291435[Abstract]
-
Payne AH, OShaughnessy PJ 1996 Structure, function and
regulation of steroidogenic enzymes in the Leydig cell. In: Payne AH,
Hardy MP, Russell LD (eds) The Leydig cell. Cache River Press, Vienna,
IL, pp 259284
-
Geierhaas B, Bornstein SR, Jarry H, Scherbaum WA, Herrmann M,
Pfeiffer EF 1991 Morphological and hormonal changes following vasectomy
in rats, suggesting a functional role for Leydig cell-associated
macrophages. Horm Metab Res 23:373378[Medline]
-
Wang J, Wreford NGM, Lan HY, Atkins R, Hedger MP 1994 Leukocyte populations of the adult rat testis following removal of the
Leydig cells by treatment with ethane dimethane sulfonate and
subcutaneous testosterone implants. Biol Reprod 51:551561[Abstract]
-
van Rooijen N, Sanders A 1994 Liposome mediated depletion of
macrophages: mechanism of action, preparation of liposomes and
applications. J Immunol Methods 174:8393[CrossRef][Medline]
-
Gaytan F, Bellido C, Aguilar E, van Rooijen N 1995 Pituitary-testicular axis in rats lacking testicular macrophages. Eur J
Endocrinol 132:218222[Medline]
-
Gaytan F, Bellido C, Aguilar E, van Rooijen N 1994 Requirement
for testicular macrophages in Leydig cells proliferation and
differentiation during prepubertal development in rats. J Reprod Fertil 102:393399[Abstract]
-
Kerr JB, Sharpe RM 1985 Stimulatory effect of
follicle-stimulating hormone on rat Leydig cells. A morphometric and
ultrastructural study. Cell Tissue Res 239:405415[Medline]
-
Hardy MP, Zirkin BR, Ewing LL 1989 Kinetic studies on the
development of the adult population of Leydig cells in testes of the
pubertal rat. Endocrinology 124:762770[Abstract]
-
Xiong Y, Hales DB 1993 Expression, regulation and production
of tumor necrosis factor-alpha in mouse testicular interstitial
macrophages in vitro. Endocrinology 133:25682573[Abstract]
-
Hales DB 1992 Interleukin-1 inhibits Leydig cell
steroidogenesis primarily by decreasing
17alpha-hydroxylase/C1720 lyase cytochrome P450 expression.
Endocrinology 131:21652172[Abstract]
-
Xiong Y, Hales DB 1993 The role of tumor necrosis factor-alpha
in the regulation of mouse Leydig cell steroidogenesis. Endocrinology 132:24382444[Abstract]
-
Hutson JC 1993 Secretion of tumor necrosis factor alpha by
testicular macrophages. J Reprod Immunol 23:6372[CrossRef][Medline]
-
Xiong Y, Hales DB 1994 Immune-endocrine interactions in the
mouse testis: cytokine-mediated inhibition of Leydig cell
steroidogenesis. Endocrine J 9:12771283
-
Kerr JB, Rich KA, De Kretser DM 1979 Alterations of the fine
structure and androgen secretion of interstitial cells in the
experimentally cryptorchid rat testis. Biol Reprod 20:409422[Medline]
-
Rich KA, Kerr JB, Krester DM 1979 Evidence for Leydig cell
dysfunction in rats with seminiferous tubule damage. Mol Cell
Endocrinol 13:123135[CrossRef][Medline]
-
Bergh A, Ason Berg A, Damber JE, Hammar M, Selstam G 1984 Steroid biosynthesis and Leydig cell morphology in adult unilaterally
cryptorchid rats. Acta Endocrinol (Copenh) 107:556562[Medline]
-
Risbridger GP, Kerr JB, De Kretser DM 1981 Evaluation of
Leydig cell function and gonadotropin binding in unilateral and
bilateral cryptorchidism: evidence for local control of Leydig cell
function by the seminiferous tubule. Biol Reprod 24:534540[Medline]
-
Carr I, Carr J 1962 Membranous whorls in the testicular
interstitial cell. Anat Rec 144:143147[Medline]
-
Ojeda SR, Urbanski HF 1994 Puberty in the rat. In: Knobil E,
Neill JD (eds) The Physiology of Reproduction, ed 2. Raven Press, Ltd.,
New York, pp 363409
-
Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA 1995 Targeted disruption of the pituitary glycoprotein hormone
-subunit produces hypogonadal and hypothyroid mice. Genes
Dev 9:20072019[Abstract]
-
Schally AV, Arimura A, Baba Y, Nair RM, Matsuo H, Redding TW,
Debeljuk L 1971 Isolation and properties of the FSH and LH-releasing
hormone. Biochem Biophys Res Commun 43:393399[Medline]
-
Amoss M, Burges R, Blackwell R, Vale W, Fellowes R, Guillemin
R 1971 Purification, amino acid composition and N-terminus of the
hypothalamic luteinizing hormone releasing factor (LRF) of ovine
origin. Biochem Biophys Res Commun 44:205210[Medline]
-
Cohen PE, Milligan SR 1993 Silastic implants for delivery of
oestradiol to mice. J Reprod Fertil 99:219223[Abstract]
-
Chandrashekar V, Bartke A, Wagner TE 1988 Endogenous human
growth hormone (GH) modulates the effect of gonadotropin-releasing
hormone on pituitary function and the gonadotropin response to the
negative feedback effect of testosterone in adult male transgenic mice
bearing human GH gene. Endocrinology 123:27172722[Abstract]
-
Klinefelter GR, Kelce WR, Hardy MP 1993 Isolation and culture
of leydig cells from adult rats. Methods Toxicol 3A:166181
-
Yeung YG, Berg KL, Pixley FJ, Angeletti RH, Stanley ER 1992 Protein tyrosine phosphatase-1C is rapidly phosphorylated in
tyrosine in macrophages in response to colony stimulating
factor-1. J Biol Chem 267:2344723450[Abstract/Free Full Text]
-
Abbaszade IG, Clarke TR, Park CHJ, Payne AH 1995 The mouse
3ß-hydroxysteroid dehydrogenase multigene family includes two
functionally distinct groups of proteins. Mol Endocrinol 9:12141222[Abstract]
-
OShaughnessy PJ, Payne AH 1982 Differential effects of
single and repeated administration of gonadotropins on testosterone
production and steroidogenic enzymes in leydig cell populations. J
Biol Chem 257:1150311509[Free Full Text]
-
Georgiou M, Perkins LM, Payne AH 1987 Steroid
synthesis-dependent, oxygen-mediated damage of mitochondrial and
microsomal cytochrome P-450 enzymes in rat leydig cell cultures.
Endocrinology 121:13901399[Abstract]
-
Youngblood GL, Payne AH 1992 Isolation and characterization of
the mouse P450 17
-hydroxylase/C17-20-lyase gene
(Cyp17): transcriptional regulation of the gene by cyclic adenosine 3',
5'-monophosphate in MA-10 leydig cells. Mol Endocrinol 6:927934[Abstract]
-
Bain PA, Yoo M, Clarke T, Hammond SH, Payne AH 1991 Multiple
forms of mouse 3ß-hydroxysteroid dehydrogenase/
5-
4 isomerase and differential expression in gonads,
adrenal glands, liver, and kidneys of both sexes. Proc Natl Acad Sci
USA 88:88708874[Abstract]
-
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched
in ribonuclease. Biochemistry 18:52945299[Medline]
-
Saade G, London DR, Lalloz MRA, Clayton RN 1989 Regulation of
LH subunit and prolactin mRNA by gonadal hormones in mice. J Mol
Endocrinol 2:213224[Abstract]
-
Oonk RB, Krasnow JS, Beattie WG, Richards JS 1989 Cyclic
AMP-dependent and -independent regulation of cholesterol side chain
cleavage cytochrome P-450 (P-450 scc) in rat ovarian granulosa cells
and corpora lutea. cDNA and deduced amino acid sequence of rat P-450
scc. J Biol Chem 264:2193421942[Abstract/Free Full Text]